The study, by the Florida Society of Interventional Pain Physicians, evaluated mild patients six weeks following the procedure using the Zurich Claudication Questionnaire. Patients rated their overall satisfaction at a 2.02 on a scale from 1 to 4, with 1 being the highest score.
Vertos mild is FDA-approved for treating central canal stenosis of the lumbar spine.
Read the Vertos release on the MiDAS I clinical trial (pdf).
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
